Anetta L. B.
- Country
- Poland
- Department
- Neurology with Storke Unit and Neuroradiological Unit
Research Overview
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Asundexian for Ischemic Stroke Prevention in Adults Post-Acute Non-Cardioembolic Stroke or High-Risk TIA
- Efficacy and Safety Evaluation of Inebilizumab in Adults with Acetylcholine Receptor or Muscle-Specific Kinase Antibody-Positive Myasthenia Gravis
- A double-blind, randomized, placebo-controlled study to evaluate the efficacy, safety, and tolerability of intravenous ganaxolone added to standard of care in refractory status epilepticus
Data & Insights
Has run more than one trial at 152 of 442 partner sites.
Specializations
Neurological Disorders
The investigator specializes in treating severe neurological conditions, with particular focus on refractory status epilepticus and its management through innovative therapeutic approaches.
- Epilepsy Management
- Emergency Neurology
- Anticonvulsant Therapies
Their work extends to evaluating novel treatment options for patients who don't respond to standard antiepileptic medications.
Cerebrovascular Medicine
The investigator focuses on prevention and treatment of acute ischemic stroke and transient ischemic attacks, exploring innovative anticoagulation strategies.
- Stroke Prevention
- Antithrombotic Therapy
- Cerebrovascular Risk Management
Their expertise includes evaluating novel oral anticoagulants for stroke prevention in high-risk patients.
Multiple Sclerosis
The investigator specializes in treating relapsing-remitting multiple sclerosis, with expertise in evaluating innovative therapeutic approaches and biological treatments.
- Immunomodulatory Therapy
- Neuroinflammatory Disorders
- Disease-Modifying Treatments
Their work encompasses assessment of novel biological therapies for autoimmune neurological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.